The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Infectious Disease & AMR

Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use
Finance

Florey Biosciences spins out of Harvard Wyss Institute to develop a medical food aimed at managing impacts of antibiotic use

OCT 1, 2024
Phage lysin compound HY-133: Start of clinical phase I “first-in-human” study to eliminate Staphylococcus aureus
Clinical & Manufacturing

Phage lysin compound HY-133: Start of clinical phase I “first-in-human” study to eliminate Staphylococcus aureus

SEP 1, 2024
Mining the microbiome: Uncovering new antibiotics inside the human gut
Infectious Disease & AMR

Mining the microbiome: Uncovering new antibiotics inside the human gut

AUG 27, 2024
The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.
Editor's Choice

The Clinical Journey of a Novel LBP for Bacterial Vaginosis Developed by MGH& Biose Industrie.

MAY 22, 2024
Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 Study for the Prevention of Recurrent C. diff Infection
Clinical & Manufacturing

Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 Study for the Prevention of Recurrent C. diff Infection

MAY 22, 2024
A virus could help save billions of gallons of wastewater produced by fracking
Infectious Disease & AMR

A virus could help save billions of gallons of wastewater produced by fracking

MAY 8, 2024
SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients
Clinical & Manufacturing

SNIPR Biome receives funding from CARB-X for advancement of SNIPR001 into clinical trials in haematological cancer patients

APR 22, 2024
New enzymatic cocktail can kill tuberculosis-causing mycobacteria
Basic & Discovery Research

New enzymatic cocktail can kill tuberculosis-causing mycobacteria

APR 15, 2024
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50M Financing
Finance

BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50M Financing

MAR 7, 2024
EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections
Finance

EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections

MAR 1, 2024
BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
Infectious Disease & AMR

BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis

NOV 29, 2023